Skip to Main Content

We have a new app!

Take the Access library with you wherever you go—easy access to books, videos, images, podcasts, personalized features, and more.

Download the Access App here: iOS and Android



A 38-year-old man has been experiencing palpitations and headaches. He enjoyed good health until 1 year ago when spells of rapid heartbeat began. These became more severe and were eventually accompanied by throbbing headaches and drenching sweats. Physical examination revealed a blood pressure of 150/90 mm Hg and heart rate of 88 bpm. During the physical examination, palpation of the abdomen elicited a sudden and typical episode, with a rise in blood pressure to 210/120 mm Hg, heart rate to 122 bpm, profuse sweating, and facial pallor. This was accompanied by severe headache. What is the likely cause of his episodes? What caused the blood pressure and heart rate to rise so high during the examination? What treatments might help this patient?

Catecholamines play a role in many physiologic and pathophysiologic responses, as described in Chapter 9 *. Drugs that block their receptors therefore have important effects, some of which are of great clinical value. These effects vary dramatically according to the drug’s selectivity for α and β receptors. The classification of adrenoceptors into α1, α2, and β subtypes and the effects of activating these receptors are discussed in Chapters 6 and 9. Blockade of peripheral dopamine receptors is of limited clinical importance at present. In contrast, blockade of central nervous system (CNS) dopamine receptors is very important; drugs that act on these receptors are discussed in Chapters 21 and 29. This chapter deals with pharmacologic antagonist drugs whose major effect is to occupy α1, α2, or β receptors outside the CNS and prevent their activation by catecholamines and related agonists.

For pharmacologic research, α1- and α2-adrenoceptor antagonist drugs have been very useful in the experimental exploration of autonomic function. In clinical therapeutics, nonselective α antagonists are used in the treatment of pheochromocytoma (tumors that secrete catecholamines), and α1-selective antagonists are used in primary hypertension and benign prostatic hyperplasia. Beta-receptor antagonist drugs are useful in a much wider variety of clinical conditions and are firmly established in the treatment of hypertension, ischemic heart disease, arrhythmias, endocrinologic and neurologic disorders, glaucoma, and other conditions.


The authors thank Dr. Randy Blakely for helpful comments, Dr. Brett English for improving tables, and our students at Vanderbilt for advice on conceptual clarity.


Mechanism of Action

Alpha-receptor antagonists may be reversible or irreversible in their interaction with these receptors. Reversible antagonists dissociate from receptors, and the block can be surmounted with sufficiently high concentrations of agonists; irreversible drugs do not dissociate and cannot be surmounted. Phentolamine and prazosin (Figure 10–1) are examples of reversible antagonists. These drugs and labetalol—drugs used primarily for their antihypertensive effects—as well as several ergot derivatives (see Chapter ...

Pop-up div Successfully Displayed

This div only appears when the trigger link is hovered over. Otherwise it is hidden from view.